Worldwide Clinical Research, Bioanalytical, Pharmacovigilance, and Training Services are offered by Norwich Clinical Services, a Contract Research Organization (CRO). The CRO has its headquarters in Bangalore, India, and its leadership team has extensive insight, knowledge, and experience in the conduct of bioavailability/bioequivalence (BABE) studies, clinical research spanning phases I through IV, pharmacovigilance, and training services.
The majority of international regulatory organizations, including the FDA, WHO, ANVISA, MOH Turkey, EMA, and CDSCO India, have examined our facilities. All of our services are carried out strictly in accordance with the most recent GCP, GLP, and 21 CFR (part 11) as well as all other relevant guidance. We have cutting-edge facilities and unmatched expertise to conduct Phase I, II, and III studies, as well as bioavailability and bioequivalence tests, pharmacokinetic tests in patients and healthy volunteers, drug metabolism tests, dose proportionality tests, multiple-dose tests, and clinical development programs.
Our staff has extensive knowledge of a range of dosage forms, including parenteral, suspensions, topical treatments, and formulations for delayed release. We provide a full variety of Clinical, Bioanalytical, Pharmacovigilance, and Training Services by combining comprehensive services with outstanding customer care. Lotus Pharmaceuticals is a company that owns Norwich Clinical Services.